These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19644620)

  • 1. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial immunotherapies for infectious diseases.
    Hengel H; Masihi KN
    Int Immunopharmacol; 2003 Aug; 3(8):1159-67. PubMed ID: 12860171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibodies for treating infectious diseases].
    Klinguer-Hamour C; Caussanel V; Beck A
    Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive antibody therapy for infectious diseases.
    Casadevall A; Dadachova E; Pirofski LA
    Nat Rev Microbiol; 2004 Sep; 2(9):695-703. PubMed ID: 15372080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases.
    Dadachova E; Casadevall A
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1075-84. PubMed ID: 16296810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody based target tailored antimicrobial chemotherapy - a new approach.
    Singla M
    Med Hypotheses; 2007; 68(5):957-9. PubMed ID: 17141970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biotechnologic drugs and chemotherapy for infectious diseases].
    Honorato J
    Rev Esp Quimioter; 2007 Sep; 20(3):310-6. PubMed ID: 18080027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IL-15 in immune-mediated and infectious diseases.
    Di Sabatino A; Calarota SA; Vidali F; Macdonald TT; Corazza GR
    Cytokine Growth Factor Rev; 2011 Feb; 22(1):19-33. PubMed ID: 21074481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.
    Ter Meulen J
    Infect Dis Clin North Am; 2011 Dec; 25(4):789-802. PubMed ID: 22054756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for passive immunotherapy in infectious diseases].
    Baumgartner JD
    Schweiz Med Wochenschr; 1987 Jan; 117(3):84-90. PubMed ID: 3823822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody production: polyclonal-derived biotherapeutics.
    Newcombe C; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):2-7. PubMed ID: 16893686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological Evolution in the Development of Therapeutic Antibodies.
    Fajardo-Ramírez ÓR; Ascacio-Martínez JA; Licea-Navarro AF; Villela-Martínez LM; Barrera-Saldaña HA
    Rev Invest Clin; 2015; 67(3):158-69. PubMed ID: 26202739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoprophylaxis of respiratory infections].
    Dreffier C; Ramisse F; Alonso JM
    Med Sci (Paris); 2004 Nov; 20(11):999-1003. PubMed ID: 15525495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in the pathology of infective agents].
    Cosentino S; Russo R; Fatuzzo F; Nunnari A
    Minerva Med; 1984 Oct; 75(38):2199-206. PubMed ID: 6438562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinued drugs in 2008: anti-infectives.
    Ryder NS
    Expert Opin Investig Drugs; 2010 Jan; 19(1):1-21. PubMed ID: 20001552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic antibodies for infectious diseases.
    Sparrow E; Friede M; Sheikh M; Torvaldsen S
    Bull World Health Organ; 2017 Mar; 95(3):235-237. PubMed ID: 28250538
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody-based therapies for emerging infectious diseases.
    Casadevall A
    Emerg Infect Dis; 1996; 2(3):200-8. PubMed ID: 8903230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement as effector system in cancer immunotherapy.
    Macor P; Tedesco F
    Immunol Lett; 2007 Jul; 111(1):6-13. PubMed ID: 17572509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies in infectious diseases: new partners in the therapeutic arsenal].
    Desoubeaux G; Pelegrin M
    Med Sci (Paris); 2019 Dec; 35(12):1008-1013. PubMed ID: 31903909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.